Gulek, Remelyn T.

HRN: 21-28-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/23/2022
04/29/2022
IV
590
Q6
PCACP

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines